[Federal Register Volume 62, Number 47 (Tuesday, March 11, 1997)]
[Notices]
[Pages 11215-11216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6005]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute of Allergy and Infectious Diseases Special Emphasis
Panel (SEP) meetings:
Name of SEP: TB Research Materials and Vaccine Testing
(Telephone Conference Call.)
Date: March 31, 1997.
Time: 2:00 p.m.
Place: Teleconference, 6003 Executive Boulevard, Solar Bldg.,
Room 1A4, Bethesda, MD 20892 (301) 496-2550.
Contact Person: Dr. Madelon Halula, Scientific Review Adm., 6003
Executive Boulevard, Solar Bldg., Room 4C16, Bethesda, MD 20892
(301) 496-2550.
Purpose/Agenda: To evaluate contract proposals.
Name of SEP: International Training and Research in Emerging
Infectious Diseases.
Date: May 13-14, 1997.
Time: 8:30 a.m.
[[Page 11216]]
Place: Ramada Bethesda, 8400 Wisconsin Avenue, Bethesda, MD
20814 (301) 654-1000.
Contact Person: Dr. Stanley Oaks, Scientific Review Adm., 6003
Executive Boulevard, Solar Bldg., Room 4C06, Bethesda, MD 20892
(301) 496-7042.
Purpose/Agenda: To evaluate grant applications.
These meetings will be closed in accordance with the provisions
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.855,
Immunology, Allergic and Immunologic Diseases Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health.)
Dated: March 5, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-6005 Filed 3-10-97; 8:45 am]
BILLING CODE 4140-01-M
